List view / Grid view
27 March 2014 | By Merck
Merck announced the appointment of Robert M. Davis as executive vice president and chief financial officer, effective April 23, 2014....
27 March 2014 | By Bristol-Myers Squibb
Blood pressure control key factor in stroke risk...
27 March 2014 | By WITec
TESCAN ORSAY HOLDING, a.s. and WITec GmbH jointly launch RISE Microscopy at Analytica 2014...
26 March 2014 | By The European Medicines Agency
Handling of all other evaluation procedures to remain unchanged until further announcement later this year...
26 March 2014 | By Pfizer
Pfizer Inc. announced the top-line results from a Phase 3B study evaluating the 24-month efficacy of GENOTROPIN®...
26 March 2014 | By GlaxoSmithKline
GlaxoSmithKline plc announced that the European Commission has granted marketing authorisation for its once-weekly diabetes treatment, Eperzan® (albiglutide)...
26 March 2014 | By AstraZeneca
AstraZeneca today announced it has completed the purchase of Sumitomo Chemical’s remaining shares in AstraZeneca K.K...
26 March 2014 | By kdm communications
Syrris is pleased to announce the launch of the Asia Tube Cooler, the latest addition to the Company’s range of advanced flow chemistry products...
26 March 2014 | By Cancer Research UK
Cancer Research UK’s Drug Development Office has launched a trial of a vaccine to treat some forms of cancer caused by a common virus known as the Epstein Barr Virus...
25 March 2014 | By kdm communications
Tecan offers a wide range of laboratory automation solutions for mass spectrometry sample preparation, ensuring there is a system to meet your workflow and throughput needs...
25 March 2014 | By Daiichi Sankyo
Daiichi Sankyo Company, Limited announced its TaNeDS (Take a New challenge for Drug diScovery) collaborative drug discovery project for 2014...
24 March 2014 | By Daiichi Sankyo
Daiichi Sankyo Company, Limited announced late-breaking data from two pre-specified subgroup analyses of East Asian patients with non-valvular atrial fibrillation or venous thromboembolism enrolled in two phase 3 edoxaban studies...
24 March 2014 | By Daiichi Sankyo
Daiichi Sankyo Company, Limited announced that it has received approval from the Ministry of Health, Labour and Welfare in Japan for the antiplatelet agent Efient® 3.75mg/5mg Tablets...
24 March 2014 | By AbbVie
AbbVie will present new data from its phase III hepatitis C development program at the 2014 International Liver Congress™...
24 March 2014 | By Merck
Merck announced that new Phase 2 data for its two investigational hepatitis C virus (HCV) treatments are scheduled to be presented at the 49th Annual Meeting of the European Association for the Study of the Liver...
